MAZZEO, SALVATORE
 Distribuzione geografica
Continente #
EU - Europa 1.566
AS - Asia 1.310
NA - Nord America 907
SA - Sud America 208
AF - Africa 37
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.038
Nazione #
US - Stati Uniti d'America 858
RU - Federazione Russa 817
SG - Singapore 536
CN - Cina 409
IT - Italia 401
BR - Brasile 167
HK - Hong Kong 150
VN - Vietnam 107
DE - Germania 68
FR - Francia 65
GB - Regno Unito 50
NL - Olanda 35
CA - Canada 28
IN - India 27
FI - Finlandia 24
AT - Austria 23
PL - Polonia 21
ES - Italia 18
AR - Argentina 16
MX - Messico 15
SE - Svezia 15
JP - Giappone 14
TR - Turchia 10
ZA - Sudafrica 10
LT - Lituania 9
AU - Australia 8
BD - Bangladesh 7
IQ - Iraq 7
CO - Colombia 6
SA - Arabia Saudita 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
ID - Indonesia 5
TN - Tunisia 5
UA - Ucraina 5
UZ - Uzbekistan 4
BE - Belgio 3
BO - Bolivia 3
EC - Ecuador 3
GH - Ghana 3
IL - Israele 3
KE - Kenya 3
MA - Marocco 3
NP - Nepal 3
PH - Filippine 3
CL - Cile 2
DZ - Algeria 2
EG - Egitto 2
HN - Honduras 2
MY - Malesia 2
OM - Oman 2
PY - Paraguay 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
UY - Uruguay 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CH - Svizzera 1
CI - Costa d'Avorio 1
GA - Gabon 1
GD - Grenada 1
GT - Guatemala 1
HR - Croazia 1
IE - Irlanda 1
JM - Giamaica 1
JO - Giordania 1
KZ - Kazakistan 1
LB - Libano 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
MW - Malawi 1
NR - Nauru 1
PE - Perù 1
PK - Pakistan 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SC - Seychelles 1
SY - Repubblica araba siriana 1
TG - Togo 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.038
Città #
Singapore 331
Dallas 226
Moscow 175
Hong Kong 145
Ashburn 134
San Jose 94
Beijing 65
Shanghai 52
Hefei 50
Lauterbourg 42
Los Angeles 41
Milan 38
Ho Chi Minh City 36
Orem 29
Nardò 28
Tito 28
New York 27
Council Bluffs 25
Nuremberg 23
Hanoi 21
São Paulo 16
Taranto 16
Chennai 15
Rome 15
Santa Clara 15
London 13
Munich 13
Warsaw 12
Atlanta 11
Florence 11
Guangzhou 11
Stockholm 11
Tokyo 11
Houston 10
Mexico City 10
Amsterdam 9
Boardman 9
Falkenstein 9
Helsinki 9
Montreal 9
Phoenix 9
Toronto 9
Boston 8
Cascina 8
Frankfurt am Main 8
Johannesburg 8
Pietragalla 8
Sydney 8
Vienna 8
Bari 7
Denver 7
Haiphong 7
Poplar 7
Seattle 7
Tianjin 7
Turin 7
Turku 7
Ankara 6
Belo Horizonte 6
Lappeenranta 6
Bologna 5
Campinas 5
Hangzhou 5
Rio de Janeiro 5
Shenzhen 5
Bexley 4
Brooklyn 4
Catania 4
City of London 4
Curitiba 4
Da Nang 4
Ha Long 4
Naples 4
Nocera Inferiore 4
Riyadh 4
Salvador 4
Tashkent 4
Washington 4
Wolfhagen 4
Wroclaw 4
Accra 3
Brasília 3
Brussels 3
Catanzaro 3
Forlì 3
Fortaleza 3
Foshan 3
Francavilla al Mare 3
Genoa 3
Guarulhos 3
Manchester 3
Mumbai 3
New Delhi 3
Palermo 3
Pittsburgh 3
Reston 3
Roubaix 3
San Francisco 3
Thái Nguyên 3
Tunis 3
Totale 2.138
Nome #
Drug prescription and delirium in older inpatients: Results from the nationwide multicenter Italian Delirium Day 2015-2016 263
The HTT gene influences plasma neurofilament light chain and brain metabolism in prodromal Alzheimer’s disease 154
Comparing two picture naming tasks in primary progressive aphasia: Insights from behavioural and neural results 147
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 123
Degradation of EEG microstates patterns in subjective cognitive decline and mild cognitive impairment: Early biomarkers along the Alzheimer's Disease continuum? 102
Usefulness of the adult concentration inventory in the psychological assessment of adult sleep disorder patients 92
Assessing the effectiveness of subjective cognitive decline plus criteria in predicting the progression to Alzheimer’s disease: an 11-year follow-up study 90
Gender Differences in Obstructive Sleep Apnea: A Preliminary Clinical and Polysomnographic Investigation 89
Cerebral amyloid load determination in a clinical setting: interpretation of amyloid biomarker discordances aided by tau and neurodegeneration measurements 87
Data-driven subtypes of mixed semantic-logopenic primary progressive aphasia: Linguistic features, biomarker profiles and brain metabolic patterns 86
Rheumatoid meningitis: a challenging diagnosis for neurologists 86
Understanding Factors Associated With Psychomotor Subtypes of Delirium in Older Inpatients With Dementia 86
A case of recurrent progressive multifocal leukoencephalopathy after human stem cell transplant, with detection of John Cunningham virus and human herpesvirus 6 on cerebrospinal fluid, treated with Mirtazapine, Olanzapine and Foscarnet 84
Early functional MRI changes in a prodromal semantic variant of primary progressive aphasia: a longitudinal case report 83
Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia 81
The dual effect of cholesterol on cognitive functions in REM sleep behavior disorder: A pilot study 80
Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia 79
CHRNA7 Gene and Response to Cholinesterase Inhibitors in an Italian Cohort of Alzheimer's Disease Patients 78
Dysphagia in primary progressive aphasia: Clinical predictors and neuroanatomical basis 77
Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus 77
Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment 77
Heterogeneity and overlap in the continuum of linguistic profile of logopenic and semantic variants of primary progressive aphasia: a Profile Analysis based on Multidimensional Scaling study 75
The effect of cag repeats within the non-pathological range in the htt gene on cognitive functions in patients with subjective cognitive decline and mild cognitive impairment 74
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment 74
Cerebrospinal fluid biomarkers for dementia: A case of post-lumbar puncture epidural hematoma 74
Differences and Similarities in Empathy Deficit and Its Neural Basis between Logopenic and Amnesic Alzheimer's Disease 73
A case of hemichorea/hemiballismus in a patient with Alzheimer’s disease and history of Sydenham’s chorea: the return of an old acquaintance? 72
CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up Study 70
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 69
Depressive Symptoms Moderate the Association Between Functional Level at Admission to Intensive Post-Stroke Rehabilitation and Effectiveness of the Intervention 69
Neurofilament Light Chain and Intermediate HTT Alleles as Combined Biomarkers in Italian ALS Patients 68
Acute Symptomatic Sinus Bradycardia in High-Dose Methylprednisolone Therapy in a Woman With Inflammatory Myelitis: A Case Report and Review of the Literature 65
Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline and Mild Cognitive Impairment 63
Expanding the Framework on Multimodal Biomarkers in iRBD. Response to Carpi et al 61
Primary progressive aphasia: six questions in search of an answer 60
Influence of apoe genotype and clock t3111c interaction with cardiovascular risk factors on the progression to alzheimer’s disease in subjective cognitive decline and mild cognitive impairment patients 60
Matching clinical diagnosis and amyloid biomarkers in alzheimer’s disease and frontotemporal dementia 60
Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia 59
Gender differences in cognitive reserve: implication for subjective cognitive decline in women 57
Unravelling neural correlates of empathy deficits in Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease 57
Data-driven subtypes of subjective cognitive decline: neuropsychological profiles, Alzheimer’s disease biomarkers, and clinical trajectories 55
The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment 55
The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study 53
The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: a 7-year follow-up study 53
KIBRA T allele influences memory performance and progression of cognitive decline: a 7-year follow-up study in subjective cognitive decline and mild cognitive impairment 52
Tracking prodromal α-synucleinopathies: novel fluid- and tissue-based biomarker approaches for iRBD phenoconversion 51
PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer's Disease With machine learning: the PREVIEW study protocol 51
Per2 C111G polymorphism influences cognition in Subjective Cognitive Decline and Mild Cognitive Impairment. A 10-year follow-up study 49
Intermediate alleles of HTT: A new pathway in longevity 48
From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study 46
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 46
Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross‐sectional and longitudinal study 45
Personalized modeling of Alzheimer's disease progression estimates neurodegeneration severity from EEG recordings 44
Mutational Landscape of Alzheimer’s Disease and Frontotemporal Dementia: Regional Variances in Northern, Central, and Southern Italy 43
Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14-year follow-up study 41
Future perspective and clinical applicability of the combined use of plasma phosphorylated tau 181 and neurofilament light chain in Subjective Cognitive Decline and Mild Cognitive Impairment 40
Dural arteriovenous fistula presenting as temporal venous engorgement 23
Early stages of cognitive decline are characterized by different EEG microstates dynamics 2
Early-phase fluid diagnostic biomarkers in acute ischemic stroke: a hybrid umbrella review 2
P300 event-related potential in patients with cognitive decline correlates with task performance 2
A machine learning model to predict progression from subjective cognitive decline to mild cognitive impairment and dementia: a 12‐year follow‐up study 1
Staging Language‐Led Neurodegenerative Diseases in a Language‐Based World: The Challenge of the PPA-Squared Scale 1
Plasma neurofilament light chain predicts Alzheimer’s disease in patients with subjective cognitive decline and mild cognitive impairment: a longitudinal study 1
Totale 4.185
Categoria #
all - tutte 14.367
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.367


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221 0 0 0 1 0 0 0 0 0 0 0 0
2022/20236 2 1 0 0 1 1 0 1 0 0 0 0
2023/2024109 0 0 2 0 0 5 0 87 6 1 5 3
2024/2025820 47 15 1 122 87 55 158 75 99 52 39 70
2025/20263.247 186 199 285 441 331 121 318 294 912 160 0 0
Totale 4.185